Literature DB >> 5007685

Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro.

C J Cheng, S Fujimura, D Grunberger, I B Weinstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5007685

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  17 in total

1.  An analysis of synergistic sensitization.

Authors:  H P Leenhouts; K H Chadwick
Journal:  Br J Cancer Suppl       Date:  1978-06

2.  Selective activation of human heat shock gene transcription by nitrosourea antitumor drugs mediated by isocyanate-induced damage and activation of heat shock transcription factor.

Authors:  R A Kroes; K Abravaya; J Seidenfeld; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  ACNU, MTX and 5-FU penetration of rat brain tissue and tumors.

Authors:  T Y Huang; N Arita; T Hayakawa; Y Ushio
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 4.  What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.

Authors:  S Amarasingh; M R Macleod; I R Whittle
Journal:  J Neurooncol       Date:  2008-09-24       Impact factor: 4.130

5.  Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat.

Authors:  R A Kramer; M G McMenamin; M R Boyd
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).

Authors:  H Waldbaur; H Kuschnir; U Engelmann; H Schmidt; B Schmack
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

7.  Covalent modification of stathmin by CCNU determined by FTMS analysis of modified proteins and tryptic peptides.

Authors:  Wells W Wu; Guanghui Wang; Xing-Jie Liang; John K Park; Rong-Fong Shen
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

8.  Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.

Authors:  V A Levin; P A Kabra; M A Freeman-Dove
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

9.  Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells.

Authors:  Xing-Jie Liang; Yong Choi; Dan L Sackett; John K Park
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

10.  The hepatotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats. Ultrastructural evidence of a delayed microtubular toxicity.

Authors:  T Ducastelle; G Raguenez-Viotte; H Fouin-Fortunet; M Matysiak; J Hemet; J P Fillastre
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.